Open AccessLetter to the Editor Regarding “A Prospective, Controlled Study of the Botanical Compound Mixture LCS101 for Chemotherapy‐Induced Hematological Complications in Breast Cancer” by Yaal‐Hahoshen et al. ( The Oncologist 2011;16:1197–1202)
Author(s) -
Mooiman Kim D.,
Goey Andrew K.L.,
Meijerman Irma,
Beijnen Jos H.,
Schellens Jan H.M.
Publication year - 2012
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2011-0413
Subject(s) - medicine , taxane , breast cancer , chemotherapy , oncology , anthracycline , prospective cohort study , cancer
A prospective, randomized, placebo‐controlled study by Yaal‐Hahoshen et al. published in a recent issue of The Oncologist that concluded that the botanical mixture LCS101 prevented hematological complications in breast cancer patients undergoing anthracycline‐ and taxane‐based chemotherapy is critically reviewed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom